A retrospective pilot evaluation of switching thrombopoietic receptor-agonists in immune thrombocytopenia
about
Bidirectional inefficacy or intolerability of thrombopoietin receptor agonists: new data and a concise review.Contemporary treatment of immune thrombocytopenia.Long-term use of the thrombopoietin-mimetic romiplostim in children with severe chronic immune thrombocytopenia (ITP).Use of eltrombopag after romiplostim in primary immune thrombocytopenia.Treatment patterns and clinical outcomes in patients with chronic immune thrombocytopenia (ITP) switched to eltrombopag or romiplostim.Efficacy and safety of eltrombopag in adult refractory immune thrombocytopenia.Signal for Thrombosis with Eltrombopag and Romiplostim: A Disproportionality Analysis of Spontaneous Reports Within VigiBase®.Thrombopoietin Receptor Agonists Are Often Ineffective in Immune Thrombocytopenia and/or Cause Adverse Reactions: Results from One Hand.State of the art - how I manage immune thrombocytopenia.Immune thrombocytopenia successfully treated with eltrombopag following multiple therapies including romiplostim.Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers.Safety and efficacy of romiplostim in patients with eltrombopag-resistant or -intolerant immune thrombocytopenia.Recent advances in understanding and management of acquired thrombocytopenia.Thrombopoietin receptor agonist switch in adult primary immune thrombocytopenia patients: A retrospective collaborative survey involving 4 Spanish centres.Sequential treatment with thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): experience in our center.A United Kingdom Immune Thrombocytopenia (ITP) Forum review of practice: thrombopoietin receptor agonists.Eltrombopag in immune thrombocytopenia: efficacy review and update on drug safety.Platelet fluctuations during thrombopoietin-receptor agonist treatment: correlation with platelet apoptosis
P2860
Q31158985-2EFD67EF-7D43-4BF0-A9F2-D32D63AC5B95Q33410653-1E001598-B549-4A09-AF06-5335C644BEBFQ33418391-4D231CA0-BEB3-4484-98C1-25C8569C90B0Q33419404-2441377F-79E6-4C6B-9EAE-6D356258F08DQ33419763-D53305D1-F69D-48FB-82B3-BD0E23FCB702Q33421634-FCE52DA9-AFCE-4238-A920-F474B3DEEE3CQ33425628-EA2353EE-19BC-4EED-B1F9-95AB159469F6Q33436292-B8D08AA9-FF0B-4644-B79F-67EAAA9DB070Q33440145-CFC87405-1068-47FD-BB47-A1593C24E4BFQ42430722-E8868A10-AA0C-483F-88E0-2FE4982F3536Q45872843-C73CB0E1-A3A3-42B2-828D-E4AFFF99E60AQ45985398-AFA56460-ABE7-4838-AAF7-DC088D81C22CQ48109292-C8EFEA2F-8D20-405F-8C02-F8633B0022A9Q48320457-B0845199-8179-4FDD-B71F-BA93FA7CB466Q51263850-35934D42-8BD0-472F-98BD-4818B0513B1CQ52812834-BF573796-DF3C-4041-91B6-353F59BE244AQ54922450-9D06949E-FD04-4366-B219-A8C51D8F5712Q56971079-8D25E771-C11D-458A-8951-EBF56E0DC335
P2860
A retrospective pilot evaluation of switching thrombopoietic receptor-agonists in immune thrombocytopenia
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A retrospective pilot evaluati ...... sts in immune thrombocytopenia
@ast
A retrospective pilot evaluati ...... sts in immune thrombocytopenia
@en
type
label
A retrospective pilot evaluati ...... sts in immune thrombocytopenia
@ast
A retrospective pilot evaluati ...... sts in immune thrombocytopenia
@en
prefLabel
A retrospective pilot evaluati ...... sts in immune thrombocytopenia
@ast
A retrospective pilot evaluati ...... sts in immune thrombocytopenia
@en
P2093
P2860
P50
P1433
P1476
A retrospective pilot evaluati ...... sts in immune thrombocytopenia
@en
P2093
Charles Dauriac
François Lefrere
Françoise Roudot-Thoraval
Jean-François Abgrall
Jean-François Viallard
Jean-Marc Durand
Jean-Marie Michot
Laetitia Languille
Marc Michel
Mathilde Niault
P2860
P304
P356
10.3324/HAEMATOL.2012.074633
P577
2013-02-26T00:00:00Z